“Therapeutic Use of Tolvaptan in Cancer-Related Hyponatremia: Benefits, Risks, and Clinical Guidance”, IJERAMS, vol. 2, no. 4, pp. 10–18, Apr. 2026, doi: 10.65477/j29hcv64.